Your browser doesn't support javascript.
loading
Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial.
Loibl, Sibylle; Treue, Denise; Budczies, Jan; Weber, Karsten; Stenzinger, Albrecht; Schmitt, Wolfgang D; Weichert, Wilko; Jank, Paul; Furlanetto, Jenny; Klauschen, Frederick; Karn, Thomas; Pfarr, Nicole; von Minckwitz, Gunter; Möbs, Markus; Jackisch, Christian; Sers, Christine; Schneeweiss, Andreas; Fasching, Peter A; Schem, Christian; Hummel, Michael; van Mackelenbergh, Marion; Nekljudova, Valentina; Untch, Michael; Denkert, Carsten.
Affiliation
  • Loibl S; German Breast Group, Neu-Isenburg, Germany. Sibylle.Loibl@gbg.de.
  • Treue D; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Berlin, Germany.
  • Budczies J; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Berlin, Germany.
  • Weber K; German Cancer Consortium (DKTK), Partner Sites Berlin and Munich, Germany.
  • Stenzinger A; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Schmitt WD; German Breast Group, Neu-Isenburg, Germany.
  • Weichert W; German Cancer Consortium (DKTK), Partner Sites Berlin and Munich, Germany.
  • Jank P; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Furlanetto J; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Berlin, Germany.
  • Klauschen F; German Cancer Consortium (DKTK), Partner Sites Berlin and Munich, Germany.
  • Karn T; Institute of Pathology, Technical University of Munich, Munich, Germany.
  • Pfarr N; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Berlin, Germany.
  • von Minckwitz G; German Breast Group, Neu-Isenburg, Germany.
  • Möbs M; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Berlin, Germany.
  • Jackisch C; German Cancer Consortium (DKTK), Partner Sites Berlin and Munich, Germany.
  • Sers C; Department of Gynecology and Obstetrics, University of Frankfurt, Frankfurt am Main, Germany.
  • Schneeweiss A; Institute of Pathology, Technical University of Munich, Munich, Germany.
  • Fasching PA; German Breast Group, Neu-Isenburg, Germany.
  • Schem C; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Berlin, Germany.
  • Hummel M; Department of Obstetrics and Gynecology and Breast Cancer Center, Sana Klinikum Offenbach, Offenbach, Germany.
  • van Mackelenbergh M; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Berlin, Germany.
  • Nekljudova V; German Cancer Consortium (DKTK), Partner Sites Berlin and Munich, Germany.
  • Untch M; National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Denkert C; Universitätsklinikum Erlangen, Erlangen, Germany.
Clin Cancer Res ; 25(13): 3986-3995, 2019 07 01.
Article in En | MEDLINE | ID: mdl-30979740
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Biomarkers, Tumor / Mutation Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2019 Document type: Article Affiliation country: Germany Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Biomarkers, Tumor / Mutation Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2019 Document type: Article Affiliation country: Germany Country of publication: United States